Download - Ckd pre dialysis management
![Page 1: Ckd pre dialysis management](https://reader034.vdocuments.mx/reader034/viewer/2022052311/559c721a1a28ab88088b45ae/html5/thumbnails/1.jpg)
CKD-PRE DIALYSIS MANAGEMENT
Shruthi K
![Page 2: Ckd pre dialysis management](https://reader034.vdocuments.mx/reader034/viewer/2022052311/559c721a1a28ab88088b45ae/html5/thumbnails/2.jpg)
Chronic kidney disease
Global health problem Rising incidence – doubled in last 15 years In India – 0nly 10% of patients with ESRD have
access to RRT
![Page 3: Ckd pre dialysis management](https://reader034.vdocuments.mx/reader034/viewer/2022052311/559c721a1a28ab88088b45ae/html5/thumbnails/3.jpg)
CKD-definition
GFR ≤ 60ml/min/1.73m that is present for ≥ 3months with or without evidence of kidney damage
OR Evidence of kidney damage with or without decreased
GFR that is present for ≥ 3months as evidenced by Microalbuminuria Proteinuria Glomerular haematuria Pathological abnormalities (e.g. abnormal biopsy) Anatomical abnormalities (e.g. scarring seen on imaging or
polycystic kidneys)
![Page 4: Ckd pre dialysis management](https://reader034.vdocuments.mx/reader034/viewer/2022052311/559c721a1a28ab88088b45ae/html5/thumbnails/4.jpg)
![Page 5: Ckd pre dialysis management](https://reader034.vdocuments.mx/reader034/viewer/2022052311/559c721a1a28ab88088b45ae/html5/thumbnails/5.jpg)
![Page 6: Ckd pre dialysis management](https://reader034.vdocuments.mx/reader034/viewer/2022052311/559c721a1a28ab88088b45ae/html5/thumbnails/6.jpg)
Pre dialysis management – Why?
Optimal pre-dialysis care improve
Morbidity Mortality Dialysis and transplantation outcome
![Page 7: Ckd pre dialysis management](https://reader034.vdocuments.mx/reader034/viewer/2022052311/559c721a1a28ab88088b45ae/html5/thumbnails/7.jpg)
CKD Predicts CVD
2.113.65
11.29
21.8
36.6
0
5
10
15
20
25
30
35
40
≥ 60 45-59 30-44 15-29 < 15
Ag
e-S
tan
da
rdiz
ed
Ra
te o
f C
ard
iov
as
cu
lar
Ev
en
ts (
pe
r 1
00
pe
rso
n-y
r)
Estimated GFR (mL/min/1.73 m2)
![Page 8: Ckd pre dialysis management](https://reader034.vdocuments.mx/reader034/viewer/2022052311/559c721a1a28ab88088b45ae/html5/thumbnails/8.jpg)
Early Treatment Makes a Difference
Brenner, et al., 2001
![Page 9: Ckd pre dialysis management](https://reader034.vdocuments.mx/reader034/viewer/2022052311/559c721a1a28ab88088b45ae/html5/thumbnails/9.jpg)
Goal
To establish diagnosis Rule out reversible causes Slow down progression Evaluate and treat complications Treat co-morbidities Reduce cardiovascular risk Prepare for replacement therapy Select & start renal replacement therapy at
appropriate time
![Page 10: Ckd pre dialysis management](https://reader034.vdocuments.mx/reader034/viewer/2022052311/559c721a1a28ab88088b45ae/html5/thumbnails/10.jpg)
Management
Treatment of reversible causes Preventing or slowing the progression of disease Treatment of the complications Identification and adequate preparation of the
patient in whom renal replacement therapy will be required
![Page 11: Ckd pre dialysis management](https://reader034.vdocuments.mx/reader034/viewer/2022052311/559c721a1a28ab88088b45ae/html5/thumbnails/11.jpg)
Treatment of reversible causes
Decreased renal perfusion Hypovolemia (such as vomiting, diarrhea, diuretic use,
bleeding) Hypotension (due to myocardial dysfunction or
pericardial disease) Infection /sepsis Drugs which lower the GFR
Urinary tract obstruction
![Page 12: Ckd pre dialysis management](https://reader034.vdocuments.mx/reader034/viewer/2022052311/559c721a1a28ab88088b45ae/html5/thumbnails/12.jpg)
Slowing the rate of progression
Proteinuria < 1 gm/day or at least 60% of baseline values Optimal level of protein intake
Not been determined 0.8 to 1.0 g/kg/day
ACEI/ARB Smoking cessation
![Page 13: Ckd pre dialysis management](https://reader034.vdocuments.mx/reader034/viewer/2022052311/559c721a1a28ab88088b45ae/html5/thumbnails/13.jpg)
Blood pressure <130/80mmHg <125/75mmHg if proteinuria >1g/day Salt restriction Antihypertensives
ACE,diuretics,CCB
Exercise
![Page 14: Ckd pre dialysis management](https://reader034.vdocuments.mx/reader034/viewer/2022052311/559c721a1a28ab88088b45ae/html5/thumbnails/14.jpg)
![Page 15: Ckd pre dialysis management](https://reader034.vdocuments.mx/reader034/viewer/2022052311/559c721a1a28ab88088b45ae/html5/thumbnails/15.jpg)
Treatment of complications
Volume overload
Salt restriction
Loop diuretics
![Page 16: Ckd pre dialysis management](https://reader034.vdocuments.mx/reader034/viewer/2022052311/559c721a1a28ab88088b45ae/html5/thumbnails/16.jpg)
Hyperkalemia Develops in the patient who is oliguric or who has an
additional problem such as a high potassium diet, increased tissue breakdown, or hypoaldosteronism
Low K+ diet – 40 to 70meq / day
Avoid NSAIDs
![Page 17: Ckd pre dialysis management](https://reader034.vdocuments.mx/reader034/viewer/2022052311/559c721a1a28ab88088b45ae/html5/thumbnails/17.jpg)
Metabolic acidosis Due to
Decreased ability to regenerate bicarbonate Reduced ammonia production Decreased hydrogen ion secretion Decreased filtration of titrable acids – sulphate,
phosphate, urate, hippurates Decreased proximal tubular re-absorption of
bicarbonate
![Page 18: Ckd pre dialysis management](https://reader034.vdocuments.mx/reader034/viewer/2022052311/559c721a1a28ab88088b45ae/html5/thumbnails/18.jpg)
Treatment of academia is desirable Bicarbonate supplementation may slow the progression
of CKD Bone buffering of the some of the excess hydrogen ion
is associated with the release of calcium and phosphate from bone, contributing to worsening of renal osteodystrophy
Uremia acidosis can increase skeletal muscle breakdown and diminish albumin synthesis leading to loss of lean body mass and muscles weakness- contributing to malnutrition
![Page 19: Ckd pre dialysis management](https://reader034.vdocuments.mx/reader034/viewer/2022052311/559c721a1a28ab88088b45ae/html5/thumbnails/19.jpg)
Therapy is targeted to maintain serum bicarbonate concentration above 23 mEq/Lit
Drug of choice : sodium bicarbonate < 0.5-1.0 mEq/kg/day
![Page 20: Ckd pre dialysis management](https://reader034.vdocuments.mx/reader034/viewer/2022052311/559c721a1a28ab88088b45ae/html5/thumbnails/20.jpg)
Hyperphosphatemia Diet restriction : 800mg/day GFR<25 to 30 ml/min: oral phosphate binders Stage 3 & 4 : between 2.7 and 4.6 mg/dL Stage 5 : between 3.5 and 5.5 mg/dL
![Page 21: Ckd pre dialysis management](https://reader034.vdocuments.mx/reader034/viewer/2022052311/559c721a1a28ab88088b45ae/html5/thumbnails/21.jpg)
Renal osteodystrophy High phosphate load and hypocalcemia stimulate
PTH secretion Leads to sec hyper parathyroidism which increases
bone resorption
![Page 22: Ckd pre dialysis management](https://reader034.vdocuments.mx/reader034/viewer/2022052311/559c721a1a28ab88088b45ae/html5/thumbnails/22.jpg)
Treatment
Control serum phosphate CKD stage-specific target levels of intact PTH
CKD stage 3: treat elevated PTH to target 35-70pg/ml
CKD stage 4 to target 70-110 pg/ml CKD stage 5 to target 150-300 pg/ml
Next step is assessment of 25-(OH)D levels and replacement with vitamin D (ergocalciferol) if levels are lower than 30 ng/mL.
![Page 23: Ckd pre dialysis management](https://reader034.vdocuments.mx/reader034/viewer/2022052311/559c721a1a28ab88088b45ae/html5/thumbnails/23.jpg)
If the intact PTH level is elevated and the serum 25-(OH)D level is higher than 30 ng/mL, treatment with an active form of vitamin D is indicated
Available options Calcitriol Alfacalcidol Doxecalciferol
![Page 24: Ckd pre dialysis management](https://reader034.vdocuments.mx/reader034/viewer/2022052311/559c721a1a28ab88088b45ae/html5/thumbnails/24.jpg)
Cinacalcet Calcimimetic Used if elevated phosphorus/Ca limit use of vit D
![Page 25: Ckd pre dialysis management](https://reader034.vdocuments.mx/reader034/viewer/2022052311/559c721a1a28ab88088b45ae/html5/thumbnails/25.jpg)
Hypertension
Cause and complication of CKD Target <130/80 or <125 /75 mmHg if proteinuria is >1
gm /day or diabetes is + Non pharmacological
Lifestyle modification Salt restriction Exercise,weight reduction Diet Smoking cessation etc….
![Page 26: Ckd pre dialysis management](https://reader034.vdocuments.mx/reader034/viewer/2022052311/559c721a1a28ab88088b45ae/html5/thumbnails/26.jpg)
Pharmacological May require 3 or more drugs Diabetes & proteinuria : treat with ACEI /ARB as 1st line
therapy Monitor Creatinine & K+ on day 3 ,7 &weekly Loop and thiazide diuretics as an adjunct therapy CVD: beta blockers CCBs Alpha blockers : prazosin,doxazosin followed by direct
vascular smooth muscle relaxant minoxidil is considered
![Page 27: Ckd pre dialysis management](https://reader034.vdocuments.mx/reader034/viewer/2022052311/559c721a1a28ab88088b45ae/html5/thumbnails/27.jpg)
Anemia
Caused by insufficient erythropoietin production ,short life span of RBCs , iron deficiency
Target Hb: 10 to 12gm% Correct iron deficiency EPO : 80 to 120units/kg/wk Alternative : darbepoietin alfa Longer acting agent Dose: 0.45µg/kg s/c once a week
![Page 28: Ckd pre dialysis management](https://reader034.vdocuments.mx/reader034/viewer/2022052311/559c721a1a28ab88088b45ae/html5/thumbnails/28.jpg)
Preparation for RRT
Counselling HD,peritoneal dialysis / renal transplant If not for transplant : vascular access should be
created in preferably native AV fistula in CKD stage 4
Venous preservation should start from stage 2 or 3 Vaccinate against hep B, pneumococcal and H
influenza infection Drug dosage according to eGFR, avoid contrast